Literature DB >> 2944688

Atrial natriuretic peptide: physiological release associated with natriuresis during water immersion in man.

J V Anderson, N D Millar, J P O'Hare, J C Mackenzie, R J Corrall, S R Bloom.   

Abstract

Thermoneutral water immersion produces a physiological increase of thoracic blood volume, raises central venous pressure and increases urinary sodium excretion by a hitherto ill-understood mechanism. We have investigated whether this enhanced sodium excretion could be mediated by the recently discovered natriuretic factor, atrial natriuretic peptide (ANP). During water immersion there was a highly significant (P less than 0.001) twofold increase of the mean plasma ANP concentration and a doubling of the mean urinary sodium excretion. Both were unchanged during the control experiments. These results are consistent with the hypotheses that ANP is released into plasma in response to central blood volume expansion and that it functions as a natriuretic hormone in normal man under physiological conditions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2944688     DOI: 10.1042/cs0710319

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  10 in total

1.  Primary renal renin secretion responding to angiotensin converting enzyme inhibition.

Authors:  P G Newrick; N Millar; M Penney; R J Corrall
Journal:  Postgrad Med J       Date:  1992-08       Impact factor: 2.401

2.  A comparison of head-down tilt with low-dose infusion of atrial natriuretic peptide in man.

Authors:  M J Allen; V T Ang; D Bennett
Journal:  J Physiol       Date:  1989-03       Impact factor: 5.182

3.  Continuous measurement of blood pressure, heart rate and left ventricular performance during and after isometric exercise in head-out water immersion.

Authors:  H Fujisawa; H Kamimura; Y Ohtsuka; T Nanbu; N Yabunaka; Y Agishi
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

Review 4.  The renin-angiotensin-aldosterone system and the cardiac natriuretic peptides.

Authors:  A M Richards
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

5.  Increase in plasma concentrations of cardiodilatin (amino terminal pro-atrial natriuretic peptide) in cardiac failure and during recumbency.

Authors:  L Meleagros; J S Gibbs; M A Ghatei; S R Bloom
Journal:  Br Heart J       Date:  1988-07

6.  Plasma concentrations of atrial natriuretic peptide during physical exercise in patients with congestive heart failure.

Authors:  M Haass; R Dietz; J Purgaj; R E Lang; W Kübler
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

7.  Human atrial natriuretic factor and renin-aldosterone in paracetamol induced fulminant hepatic failure.

Authors:  M Z Panos; J V Anderson; A Forbes; N Payne; J D Slater; L Rees; R Williams
Journal:  Gut       Date:  1991-01       Impact factor: 23.059

8.  Atrial natriuretic peptide concentrations in hypoxic secondary pulmonary hypertension: relation to haemodynamic and blood gas variables and response to supplemental oxygen.

Authors:  R J Winter; A C Davidson; D Treacher; R M Rudd; J V Anderson; L Meleagros; S R Bloom
Journal:  Thorax       Date:  1989-01       Impact factor: 9.139

9.  Combined use of water immersion and frusemide in treatment of resistant ascites in liver cirrhosis.

Authors:  F Fawthrop; J P O'Hare; N Millar; C F Weston; A E Read
Journal:  J R Soc Med       Date:  1987-12       Impact factor: 18.000

10.  A trial of the Bath Waters: the treatment of lead poisoning.

Authors:  A Heywood
Journal:  Med Hist Suppl       Date:  1990
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.